The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial (2021)
Article in International Scientific Journal
Verdonschot, JA; Ferreira, JP; Pizard, A; Pellicori, P; Brunner La Rocca, H; Clark, AL; Cosmi, F; Cuthbert, J; Girerd, N; Waring, OJ; Henkens, MH; Mariottoni, B; Petutschnigg, J; Rossignol, P; Hazebroek, MR; Cleland, JG; Zannad, F; Heymans, SR